What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up

HPB

Volumn 12, Issue 4, 2010, Pages 244-249

  Pulitanó, Carlo ^a,b   Castillo, Federico ^a   Aldrighetti, Luca ^b   Bodingbauer, Martin ^a   Parks, Rowan W ^a   Ferla, Gianfranco ^b   Wigmore, Stephen J ^a   Garden, O James ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Colorectal cancer; Disease free survival; Liver metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL TUMOR; DATA BASE; ITALY; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NOMENCLATURE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DATABASES AS TOPIC; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; TERMINOLOGY AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953561011     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00155.x     Document Type: Article

References (25)

1. Pawlik TM, Schulick RD, Choti MA. (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13:51-64.
2. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318; discussion 318-321.
3. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825.
4. Scheele J, Stangl R, Altendorf-Hofmann A. (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241-1246.
5. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766.
6. Hughes KS, Rosenstein RB, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG et al. (1988) Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of longterm survivors. Dis Colon Rectum 31:1-4.
7. Adson MA, Van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. (1984) Resection of hepatic metastases from colorectal cancer. Arch Surg 119:647-651.
8. Schlag P, Hohenberger P, Herfarth C. (1990) Resection of liver metastases in colorectal cancer - competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 16:360-365.
9. Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M et al. (2008) Analysis of prognostic factors influencing longterm survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93-103.
10. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575-4580.
11. Viganó L, Ferrero A, Lo Tesoriere R, Capussotti L. (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Longterm survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458-2464.
12. Pulitanó C, Arru M, Catena M, Guzzetti E, Vitali G, Ronzoni M et al. (2008) Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases. Ann Surg Oncol 15:1661-1669.
13. Parks R, Gonen M, Kemeny N, Jarnagin W, D'Angelica M, DeMatteo R et al. (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753-761.
14. Kaplan EL, Meier P. (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-480.
15. D'Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. (1997) Ninety-six 5-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 185:554-559.
16. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. (2007) Longterm characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol 14:1336-1346.
17. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D et al. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict longterm survival. Ann Surg 240:644-657.
18. Folprecht G, Lutz MP, Schöffski P, Seufferlein T, Nolting A, Pollert P et al. (2006) Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol 17:450-456.
19. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 (Suppl.3):1-8.
20. Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K et al. (1997) Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84:1077-1080.
21. Welsh FK, Tekkis PP, O'Rourke T, John TG, Rees M. (2008) Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decisionmaking. Surg Oncol 17:3-13.
22. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. (1999) Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 86:332-337.
23. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al. (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-722.
24. De Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626-637.
25. Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T. (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133-1138.